Biomarkers in ovarian cancer: To be or not to be

被引：39
|
作者：
Arend, Rebecca [1 ]
Martinez, Alba [1 ]
Szul, Tomasz [1 ]
Birrer, Michael J. [1 ]
机构：
[1] Univ Alabama Birmingham, 619 19th St S,176F 10390E, Birmingham, AL 35249 USA
来源：
CANCER | 2019年 / 125卷
关键词：
biomarkers; genomics; molecular signatures; ovarian cancer; targeted therapy; HOMOLOGOUS RECOMBINATION GENES; NEOADJUVANT CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; CARCINOMA; SURVIVAL; MUTATIONS; PATTERNS; SUBTYPES; THERAPY; REPAIR;
D O I：
10.1002/cncr.32595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Biomarkers are becoming increasingly important in the treatment of epithelial ovarian cancer. Recent work from many laboratories has begun to provide clinically meaningful biomarkers. This review summarizes the state of the science regarding biomarkers for stratifying early-stage patients into those who benefit from adjuvant treatment, primary debulking versus interval debulking, and specific targeted therapy. In addition, new molecular imaging technologies have been developed to allow the surgeon to resect subvisible tumor deposits. These efforts should increase clinical effectiveness while minimizing toxicities for patients.
引用
收藏
页码：4563 / 4572
页数：10
相关论文
共 50 条
  • [41] Protein biomarkers of ovarian cancer: the forest and the trees
    Nolenu, Brian M.
    Lokshin, Anna E.
    FUTURE ONCOLOGY, 2012, 8 (01) : 55 - 71
  • [42] Progress in The Study of Glycosylation of Ovarian Cancer Biomarkers
    Xue Tian
    Li Yan-Hong
    Li Zheng
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2017, 44 (10) : 865 - 876
  • [43] The role of biomarkers in the management of epithelial ovarian cancer
    Yang, Wei-Lei
    Lu, Zhen
    Bast, Robert C., Jr.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (06) : 577 - 591
  • [44] Current status on microRNAs as biomarkers for ovarian cancer
    Prahm, Kira Philipsen
    Novotny, Guy Wayne
    Hogdall, Claus
    Hogdall, Estrid
    APMIS, 2016, 124 (05) : 337 - 355
  • [45] Plasma proteomic pattern as biomarkers for ovarian cancer
    Lin, YW
    Lin, CY
    Lai, HC
    Chiou, JY
    Chang, CC
    Yu, MH
    Chu, TY
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 : 139 - 146
  • [46] Molecular features as promising biomarkers in ovarian cancer
    Buklaho, Patrycja Aleksandra
    Kisluk, Joanna
    Wasilewska, Natalia
    Niklinski, Jacek
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 32 (09): : 1029 - 1040
  • [47] Exosomes: Emerging biomarkers and targets for ovarian cancer
    Tang, Maggie K. S.
    Wong, Alice S. T.
    CANCER LETTERS, 2015, 367 (01) : 26 - 33
  • [48] Tumor vascular proteins as biomarkers in ovarian cancer
    Buckanovich, Ronald J.
    Sasaroli, Dimitra
    O'Brien-Jenkins, Anne
    Botbyl, Jeffrey
    Hammond, Rachel
    Katsaros, Dionysios
    Sandaltzopoulos, Raphael
    Liotta, Lance A.
    Gimotty, Phyllis A.
    Coukos, George
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 852 - 861
  • [49] Recent advances in the biomarkers for epithelial ovarian cancer
    Kim, Yun Hwan
    Kim, Seung Cheol
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2011, 22 (04) : 219 - 221
  • [50] Biomarkers and Strategies for Early Detection of Ovarian Cancer
    Bast, Robert C., Jr.
    Lu, Zhen
    Han, Chae Young
    Lu, Karen H.
    Anderson, Karen S.
    Drescher, Charles W.
    Skates, Steven J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (12) : 2504 - 2512
12345